Teladoc Health Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
TDOC$8.94-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Cash flows from operating activities: | |||
| Net loss | $(220,368) | $(13,659,531) | $(428,793) |
| Adjustments to reconcile net loss to net cash flows from operating activities: | |||
| Goodwill impairment | 0 | 13,402,812 | 0 |
| Depreciation | 11,138 | 11,407 | 8,941 |
| Amortization | 325,933 | 244,620 | 195,298 |
| Depreciation of rental equipment | 2,602 | 2,859 | 3,333 |
| Amortization of right-of-use assets | 11,650 | 11,757 | 12,049 |
| Provision for allowances | 4,686 | 2,815 | 10,603 |
| Stock-based compensation | 201,550 | 217,852 | 302,586 |
| Deferred income taxes | (1,903) | (7,840) | 41,800 |
| Accretion of interest | 3,400 | 3,345 | 61,253 |
| Loss on extinguishment of debt | 0 | 0 | 40,652 |
| Gain on sale of investment | 0 | 0 | (5,901) |
| Other, net | (310) | 7,584 | (3,845) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (10,252) | (49,058) | (11,172) |
| Prepaid expenses and other current assets | 12,461 | (41,081) | (31,090) |
| Inventory | 24,095 | 14,800 | (19,494) |
| Other assets | (23,052) | (27,767) | (3,547) |
| Accounts payable | (4,185) | 1,876 | 1,188 |
| Accrued expenses and other current liabilities | 9,069 | 61,217 | 18,175 |
| Accrued compensation | 19,180 | (12,290) | (4,675) |
| Deferred revenue | (4,900) | 15,240 | 20,554 |
| Operating lease liabilities | (10,224) | (11,525) | (16,532) |
| Other liabilities | (549) | 200 | 2,607 |
| Net cash provided by operating activities | 350,021 | 189,292 | 193,990 |
| Cash flows from investing activities: | |||
| Capital expenditures | (11,464) | (16,480) | (8,534) |
| Capitalized software | (144,884) | (156,284) | (55,400) |
| Proceeds from marketable securities | 0 | 2,507 | 50,000 |
| Proceeds from the sale of investment | 0 | 0 | 10,901 |
| Acquisitions of businesses, net of cash acquired | 0 | 0 | (78,663) |
| Other, net | 1 | 2,514 | 8,715 |
| Net cash used in investing activities | (156,347) | (167,743) | (72,981) |
| Cash flows from financing activities: | |||
| Net proceeds from the exercise of stock options | 1,481 | 5,884 | 25,781 |
| Proceeds from employee stock purchase plan | 9,651 | 6,501 | 16,810 |
| Cash received for withholding taxes on stock-based compensation, net | (278) | 124 | 3,422 |
| Other, net | 0 | (6,012) | (5,066) |
| Net cash provided by financing activities | 10,854 | 6,497 | 40,947 |
| Net increase in cash and cash equivalents | 204,528 | 28,046 | 161,956 |
| Effect of foreign currency exchange rate changes | 965 | (3,344) | (1,800) |
| Cash and cash equivalents at beginning of the period | 918,182 | 893,480 | 733,324 |
| Cash and cash equivalents at end of the period | $1,123,675 | $918,182 | $893,480 |
| Income taxes paid | $7,238 | $2,512 | $3,974 |
| Interest paid | $17,422 | $17,361 | $18,837 |
| Supplemental disclosure of non-cash investing activities | |||
| Accruals related to Property and equipment, net and Intangible assets, net | $11,006 | $8,216 | $5,264 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.